Saturday, July 11, 2026

Drug profile · INN

desferrioxamine

desferrioxamine (DBL DESFERRIOXAMINE MESILATE) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — desferrioxamine

Quick answer

desferrioxamine (DBL DESFERRIOXAMINE MESILATE) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd.

Key facts

INN desferrioxamine
Brand DBL DESFERRIOXAMINE MESILATE

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. DESF Phase 2 · Aquestive Therapeutics · Allergic Reaction

Frequently asked questions

What is desferrioxamine?

desferrioxamine (DBL DESFERRIOXAMINE MESILATE) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd.

What is the brand name for desferrioxamine?

DBL DESFERRIOXAMINE MESILATE is a marketed brand name for desferrioxamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.